We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$632M
AUM Growth
-$107M
Cap. Flow
-$5M
Cap. Flow %
-0.79%
Top 10 Hldgs %
31.33%
Holding
177
New
8
Increased
50
Reduced
56
Closed
21

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$10M
2
GIS icon
General Mills
GIS
+$6.88M
3
MLM icon
Martin Marietta Materials
MLM
+$5.91M
4
ZTS icon
Zoetis
ZTS
+$5.16M
5
MO icon
Altria Group
MO
+$5.06M

Top Sells

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$9.07M
2
DD icon
DuPont de Nemours
DD
+$7.89M
3
GILD icon
Gilead Sciences
GILD
+$7.41M
4
SLB icon
SLB Ltd
SLB
+$5.88M
5
GS icon
Goldman Sachs
GS
+$4.38M

Sector Composition

Rank Sector Weight
1 Financials 17.4%
2 Technology 16.74%
3 Healthcare 16.39%
4 Consumer Discretionary 12.87%
5 Consumer Staples 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFCF
126
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$240K 0.04%
5,025
+475
+10% +$22.4K
IQV icon
127
IQVIA
IQV
$38.4B
$232K 0.04%
2,000
– –
CMCSA icon
128
Comcast
CMCSA
$87.2B
$225K 0.04%
6,595
-1,986
-23% -$72.5K
CRM icon
129
Salesforce
CRM
$152B
$223K 0.04%
1,627
– –
PNC icon
130
PNC Financial Services
PNC
$100B
$216K 0.03%
1,848
– –
RYN icon
131
Rayonier
RYN
$6.48B
$208K 0.03%
8,267
– –
DGX icon
132
Quest Diagnostics
DGX
$25.6B
$202K 0.03%
+2,428
New +$228K
HPE icon
133
Hewlett Packard
HPE
$66.5B
$189K 0.03%
14,314
– –
PTGX icon
134
Protagonist Therapeutics
PTGX
$8.51B
$158K 0.03%
23,500
-3,500
-13% -$27.8K
TYME
135
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$155K 0.02%
42,000
+1,000
+2% +$2.81K
SYRE icon
136
Spyre Therapeutics
SYRE
$8.24B
$150K 0.02%
+800
New +$170K
BLCM
137
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$150K 0.02%
5,142
+130
+3% +$5.77K
SGMO
138
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$137K 0.02%
11,900
-29,000
-71% -$360K
FAT
139
DELISTED
FAT Brands
FAT
$94K 0.01%
+40,903
New +$126K
FPRX
140
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$93K 0.01%
10,000
– –
MLNT
141
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$54K 0.01%
13,590
+660
+5% +$8.44K
RIGL icon
142
Rigel Pharmaceuticals
RIGL
$693M
$47K 0.01%
2,050
– –
NVLN
143
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$39K 0.01%
46,000
+20,000
+77% +$22.6K
ADXS
144
DELISTED
Advaxis Inc
ADXS
$21K ﹤0.01%
7,320
-5,400
-42% -$41.3K
ABEO icon
145
Abeona Therapeutics
ABEO
$364M
– –
-440
Closed -$141K
ACN icon
146
Accenture
ACN
$101B
– –
-1,379
Closed -$235K
ADP icon
147
Automatic Data Processing
ADP
$107B
– –
-1,544
Closed -$233K
CLB icon
148
Core Laboratories
CLB
$491M
– –
-78,347
Closed -$9.07M
EBAY icon
149
eBay
EBAY
$47.6B
– –
-6,965
Closed -$230K
ECL icon
150
Ecolab
ECL
$78.6B
– –
-1,332
Closed -$209K
3 4 5
6
7

Similar funds

CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return

Franklin Street Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Franklin Street Advisors held 177 positions worth $632M, down 14% from $739M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Franklin Street Advisors's Q4 2018 filing shows 8 new, 50 increased, 56 reduced and 21 closed positions. Its largest new stake was General Mills: 162,890 shares worth $6.34M. The largest sale was Core Laboratories, an estimated $9.07M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Franklin Street Advisors's largest Q4 2018 buy was General Mills: 162,890 shares worth $6.34M.
  • Franklin Street Advisors added most to Activision Blizzard in Q4 2018, an estimated $10M increase.
  • Franklin Street Advisors's biggest Q4 2018 reduction was DuPont de Nemours, cutting an estimated $7.89M.
  • Franklin Street Advisors fully exited Core Laboratories in Q4 2018, selling an estimated $9.07M.
  • Franklin Street Advisors's ten largest holdings make up 31% of its $632M portfolio in Q4 2018.
  • Franklin Street Advisors opened 8 new positions and closed 21 in Q4 2018.
  • Franklin Street Advisors's portfolio value fell 14% quarter-over-quarter to $632M.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.